QS-21-Xyl is an immune system-targeted adjuvant, acting as an agonist for T-cell and B-cell immune responses. QS-21-Xyl enhances vaccine immunogenicity by activating dendritic cells and promoting antigen presentation. QS-21-Xyl is promising for research of oncology vaccines (e.g., melanoma) and infectious disease vaccines (e.g., HIV, malaria)[1].
Molecular Weight:
1990.13
Purity:
97.23
CAS Number:
[250643-56-2]
Formula:
C92H148O46
Target:
Others
Application Notes:
MCE Product type: Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted